About US
Contact us
-
GSK, Genmab to refocus on ofatumumab development program in autoimmune indicationsGlaxoSmithKline (GSK) and Genmab A/S (Copenhagen:GEN); Following the 1st July announcement by GSK and Genmab of anamendment to the collaborative agreement for ofatumumab in which GSK assumeddevelopmen2010/9/17
-
NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC ConferenceNovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infec2010/9/17
-
China International Medical Device Regulatory Forum 2010 held in BeijingIn order to promote the exchange on Chinese and international medical device regulations and company the formulation and revision of the Regulations for the Supervision and Administration of Medica2010/9/16
-
SFDA Deputy Commissioner Wu Zhen meets CEO of the Danish Medicines AgencyOn the morning of September 9, 2010, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met the visiting Jytte Lyngvig, Chief Executive Officer of the Danish Medicines A2010/9/16
-
UBM Live anticipates CPhI Worldwide attendance to exceed 25,000Leading events organiser UBM Live today announced that it expects the attendance for CPhI Worldwide, the annual flagship tradeshow for pharma ingredients, now in its 21st year and the year being held2010/9/15
-
SAMHSA to unveil results of 2009 National Survey on Drug Use and HealthThe Substance Abuse and Mental Health Services Administration (SAMHSA) will unveil the results of the latest (2009) National Survey on Drug Use and Health (NSDUH) at a press conference on Thursday, Se2010/9/15
-
DSM launches InnoSyn™ route scouting services to meet pharmaceutical company needs to outsource R&DDSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSynTM route scouting services. In response to the increasing interest of pharmaceutical customer2010/9/14
-
AB SCIEX, University of Melbourne join to develop drug metabolism studies of biopharmaceuticalsAB SCIEX, a global leader in life science analytical technologies, and the University of Melbourne today announced a joint technology development project to improve drug metabolism studies of biopharm2010/9/14
-
Lantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agentsLantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agents Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, support2010/9/13
-
K-V successfully completes FDA inspection for resumption of manufacturing and shipment of productsK-V successfully completes FDA inspection for resumption of manufacturing and shipment of products K-V Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has received notice from the U2010/9/13